Format
Sort by

Send to:

Choose Destination

Results: 2

1.

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD; PLATINUM Trial Investigators.

J Am Coll Cardiol. 2011 Apr 19;57(16):1700-8. doi: 10.1016/j.jacc.2011.02.016. Epub 2011 Apr 4.

PMID:
21470815
[PubMed - indexed for MEDLINE]
Free Article
2.

Better ischemic event-free survival after two internal thoracic artery grafts: 13 years of follow-up.

Berreklouw E, Rademakers PP, Koster JM, van Leur L, van der Wielen BJ, Westers P.

Ann Thorac Surg. 2001 Nov;72(5):1535-41.

PMID:
11722039
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk